Prodrug micelle-based nanomedicine for cancer treatment

Nanomedicine

Volumn 8, Issue 10, 2013, Pages 1559-1562

  Mi, Yu ^a   Zhao, Jing ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

anticancer drug; biodegradable polymer; cancer nanotechnology; drug delivery; drug targeting; pharmaceutical nanotechnology

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ALVESPIMYCIN; ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; DOXORUBICIN; FOLIC ACID; GELDANAMYCIN; GEMCITABINE; GLUCURONIDE; HALOPERIDOL; HYDRAZONE DERIVATIVE; MACROGOL 10000; MACROGOL 2000; PACLITAXEL; PLATINUM; POLYGLACTIN; POLYLACTIC ACID; PRODRUG; STEARIC ACID; TIOGUANINE; TRASTUZUMAB;

ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL ENCAPSULATION; CIRCULATION TIME; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TOLERANCE; DRUG TRANSPORT; ENDOSOME; HUMAN; HYDROGEL; LYSOSOME; MELANOMA; MICELLE; NANOMEDICINE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; STEREOSPECIFICITY; THERAPY EFFECT;

DRUG DELIVERY SYSTEMS; HUMANS; MICELLES; NANOMEDICINE; NEOPLASMS; PRODRUGS;

EID: 84885103639     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.121     Document Type: Review

References (26)

1. Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev. Medical Devices 1(1), 115-125 (2004).
2. Feng SS New-concept chemotherapy by nanoparticles of biodegradable polymers: Where are we now? Nanomedicine (Lond.) 1(3), 297-309 (2006).
3. Feng SS. Chemotherapeutic engineering: Concept, feasibility, safety and prospect - a tribute to Shu Chien's 80th birthday. Cell Mol. Bioeng. 4(4), 708-716 (2011).
4. Mi Y, Liu YT, Feng SS. Formulation of docetaxel by folic acid-conjugated d a tocopheryl polyethylene glycol succinate 2000 (vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 32(16), 4058-4066 (2011).
5. Xiong MP, Yanez JA, Remsberg CM et al. Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats. J. Control. Release 129(1), 33-40 (2008).
6. Zhu SJ, Lansakara-P DSP, Li XR, Cui ZR. Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its anti-tumor activity. Bioconjug. Chem. 23(5), 966-980 (2012).
7. Talelli M, Morita K, Rijcken CJF et al. Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry. Bioconjug. Chem. 22(12), 2519-2530 (2011).
8. Hans ML, Maxwell C, Ehrlichman RS et al. Evaluation of in vitro release and in vivo efficacy of mPEG-PLA-haloperidol conjugate micelle-like structures. J. Biomed. Mater. Res. B 83B(2), 422-430 (2007).
9. Xiao HH, Qi RG, Liu S et al. Biodegradable polymer-cisplatin(IV) conjugate as a pro-drug of cisplatin(II). Biomaterials 32(30), 7732-7739 (2011).
10. van der Vlies AJ, Hasegawa U, Hubbell JA. Reduction-sensitive tioguanine prodrug micelles. Mol. Pharmaceut. 9(10), 2812-2818 (2012).
11. Zhang ZP, Tan SW, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 33(19), 4889-4906 (2012).
12. Cao N, Feng SS. Doxorubicin conjugated to d a tocopheryl polyethylene glycol 1000 succinate (TPGS): Conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 29(28), 3856-3865 (2008).
13. Anbharasi V, Cao N, Feng SS. Doxorubicin conjugated to d a tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy. J. Biomed. Mater. Res. Part A 94A(3), 730-743 (2010).
14. Mi Y, Zhao J, Feng SS. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. Int. J. Pharm. 438(1-2), 98-106 (2012).
15. Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc. Natl Acad. Sci. USA 105(45), 17356-17361 (2008).
16. Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc. Natl Acad. Sci. USA 108(5), 1850-1855 (2011).
17. Kolishetti N, Dhar S, Valencia PM et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc. Natl Acad. Sci. USA 107(42), 17939-17944 (2010).
18. Aryal S, Hu CMJ, Zhang LF. Polymer-cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano 4(1), 251-258 (2010).
19. Zhang ZP, Lee SH, Gan CW, Feng SS. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy. Pharm. Res. 25(8), 1925-1935 (2008).
20. Zhang Z, Huey Lee S, Feng SS. Folate-decorated poly(lactide-co-glycolide) -vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 28(10), 1889-1899 (2007).
21. Gan CW, Feng SS. Transferrin-conjugated nanoparticles of poly(lactide)-d a tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 31(30), 7748-7757 (2010).
22. Pan J, Feng SS. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials 30(6), 1176-1183 (2009).
23. Prashant C, Dipak M, Yang CT, Chuang KH, Jun D, Feng SS. Superparamagnetic iron oxide-loaded poly(lactic acid)-d a tocopheryl polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent. Biomaterials 31(21), 5588-5597 (2010).
24. Tan YF, Chandrasekharan P, Maity D et al. Multimodal tumor imaging by iron oxides and quantum dots formulated in poly(lactic acid)-d a tocopheryl polyethylene glycol 1000 succinate nanoparticles. Biomaterials 32(11), 2969-2978 (2011).
25. Zhao J, Mi Y, Liu Y, Feng SS. Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend. Biomaterials 33(6), 1948-1958 (2012).
26. Mi Y, Zhao J, Feng SS. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. J. Control. Release 169(3), 185-192 (2013).